Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IRAK4-IN-6 is a selective and orally efficacious inhibitor of IRAK4, demonstrating an IC50 value of 4 nM. This compound specifically targets MyD88 L265P mutant diffuse large B-cell lymphoma [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,490.00 | |
50 mg | 10-14 weeks | $ 2,480.00 |
Description | IRAK4-IN-6 is a selective and orally efficacious inhibitor of IRAK4, demonstrating an IC50 value of 4 nM. This compound specifically targets MyD88 L265P mutant diffuse large B-cell lymphoma [1]. |
Targets&IC50 | IRAK4:4 nM |
Molecular Weight | 504.59 |
Formula | C25H32N10O2 |
CAS No. | 2454244-02-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IRAK4-IN-6 2454244-02-9 Others IRAK4IN6 IRAK4 IN 6 IRAK-4-IN-6 inhibitor inhibit